EEvigrade
RU

FIB-4 — non-invasive liver fibrosis index

Non-invasive index of advanced liver fibrosis from age, AST, ALT, and platelets. Used as first-line screening in NAFLD and chronic viral hepatitis.

About this calculator

FIB-4 was developed by Sterling et al. (2006) for HIV/HCV coinfected patients and validated for other chronic liver diseases. AGA Clinical Practice Guideline 2023 recommends FIB-4 as first-line fibrosis screening in NAFLD. Cutoffs: < 1.3 — fibrosis unlikely; > 2.67 — likely. In patients ≥ 65, the lower cutoff is raised to 2.0.

Source

Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317-1325.

Formula version: sterling-2006-aga-2023-v1

Related

Calculators

Drugs